Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in multimodal therapy for patients with oligometastatic peritoneal gastric cancer: a randomized multicenter phase III trial PIPAC VEROne

Peritoneal carcinomatosis is the most frequent site of metastases in patients with gastric cancer. Current standard treatment is palliative systemic chemotherapy with very poor prognosis. Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) resulted in long-ter...

Full description

Bibliographic Details

Published in:	Pleura and Peritoneum
Main Authors:	Casella Francesco, Bencivenga Maria, Rosati Riccardo, Fumagalli Uberto Romario, Marrelli Daniele, Pacelli Fabio, Macrì Antonio, Donini Annibale, Torroni Lorena, Pavarana Michele, De Manzoni Giovanni
Format:	Article
Language:	English
Published:	De Gruyter 2022-06-01
Subjects:	gastric cancer intraperitoneal chemotherapy peritoneal metastases pipac systemic chemotherapy
Online Access:	https://doi.org/10.1515/pp-2022-0111